Cargando…
Human microbiota in health and disease : from pathogenesis to therapy /
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London, United Kingdom :
Academic Press, an imprint of Elsevier,
2018.
|
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_on1038716467 | ||
| 003 | OCoLC | ||
| 005 | 20231120010258.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 180605s2018 enk ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d OPELS |d N$T |d EBLCP |d YDX |d OCLCO |d OCLCF |d UAB |d NRC |d OCLCO |d NLE |d INT |d AU@ |d OCLCO |d OCLCQ |d UKMGB |d U3W |d ITD |d OCLCO |d LVT |d DKU |d OCLCO |d OCLCQ |d OCLCO |d D6H |d OCLCO |d UPM |d OCLCO |d LQU |d OCLCQ |d OCLCA |d OCLCQ |d S2H |d OCLCO |d VT2 |d OCLCQ |d OCLCO |d K6U |d OCL |d OCLCQ |d CASUM | ||
| 016 | 7 | |a 018895777 |2 Uk | |
| 019 | |a 1105186360 |a 1105567833 |a 1229877316 |a 1235833752 | ||
| 020 | |a 9780128146507 |q (electronic bk.) | ||
| 020 | |a 0128146508 |q (electronic bk.) | ||
| 020 | |z 9780128146491 |q (print) | ||
| 020 | |z 0128146494 | ||
| 035 | |a (OCoLC)1038716467 |z (OCoLC)1105186360 |z (OCoLC)1105567833 |z (OCoLC)1229877316 |z (OCoLC)1235833752 | ||
| 050 | 4 | |a QR46 | |
| 060 | 4 | |a QW 4 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.9/041 |2 23 |
| 100 | 1 | |a Tungland, Bryan, |e author. | |
| 245 | 1 | 0 | |a Human microbiota in health and disease : |b from pathogenesis to therapy / |c Bryan Tungland. |
| 264 | 1 | |a London, United Kingdom : |b Academic Press, an imprint of Elsevier, |c 2018. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a Includes index. | ||
| 588 | 0 | |a Online resource; title from PDF title page (ScienceDirect, viewed June 6, 2018). | |
| 505 | 0 | |a Intro; Title page; Table of Contents; Copyright; Dedication; Preface; Chapter 1: Gut Microbiota, Early Colonization and Factors in its Development that Influence Health; Abstract; 1.1. Commensal gut microbiota composition and body distribution; 1.2. Early microbial colonization and factors affecting subsequent gut microbiota development; 1.3. Consequences of an infant microbiota colonization and development on health later in life; 1.4. Maternal nutrition during pregnancy and role of pro- and prebiotics in prenatal microbiota development and metabolic programing; 1.5. Conclusions. | |
| 505 | 8 | |a Chapter 2: Short-Chain Fatty Acid Production and Functional Aspects on Host MetabolismAbstract; 2.1. Introduction; Chapter 3: Gut Microbiota Influence Lipid and Glucose Metabolism, Energy Homeostasis and Inflammation Through Effects on Bile Acid Metabolism; Abstract; 3.1. Bile acid synthesis and conjugation, and their elimination or resorption; 3.2. Regulation of bile acid synthesis; 3.3. Bile acids as signaling molecules that regulate their synthesis, transport and energy; 3.4. Bile acid signaling influences glucose and lipid, and energy metabolism. | |
| 505 | 8 | |a 3.5. Bile acid signaling mediates cytokine expression and immune response in inflammation3.6. Conclusions of bile acid chapter; Chapter 4: Role of Gut Microbiota in Immune Homeostasis; Abstract; 4.1 Introduction; 4.2. Types of T cells and their function; 4.3 Gut microbiota influence innate immune homeostasis; 4.4 Gut microbiota and adaptive immune homeostasis; 4.5 Gut microbiota influence systemic threshold of activation of innate and adaptive cells; 4.6 Commensal microbiota control immunity in distal tissues. | |
| 505 | 8 | |a Chapter 5: Direct Physiological Effects on Local Gi and Indirect Systemic Effects of Prebiotic Fructan Treatment, and its Role in Disease Prevention and TherapyAbstract; 5.1. Introduction; 5.2. Beneficial effects of prebiotic fructan consumption on the physiology of the lower GI; Chapter 6: Intestinal-Based Diseases and Peripheral Infection Risk Associated with Gut Dysbiosis: Therapeutic use of Pre- and Probiotics and Fecal Microbiota Transplantation; Abstract; 6.1. Introduction. | |
| 505 | 8 | |a 6.2. Infection risk reduction, including C. difficile, and associated infectious diarrhea: effects of pro- and prebiotic, and fecal microbiota transplantation therapies (also refer to earlier section on effects of these therapeutic approaches in atopy and allergies)6.3. Gastric acid-related disorders [heartburn, gastroesophageal reflux (GERD)] and effects of pro- and/or prebiotic treatment; 6.4. Celiac disease and gluten intolerance: effects of pro- and/or prebiotic therapy; 6.5. Irritable bowel syndrome (IBS) and effects of pro- and prebiotic, and FMT therapies. | |
| 504 | |a Includes bibliographical references and index. | ||
| 650 | 0 | |a Medical microbiology. | |
| 650 | 0 | |a Microbiology. | |
| 650 | 2 | |a Microbiology |0 (DNLM)D008829 | |
| 650 | 6 | |a Microbiologie m�edicale. |0 (CaQQLa)201-0004318 | |
| 650 | 6 | |a Microbiologie. |0 (CaQQLa)201-0003856 | |
| 650 | 7 | |a microbiology. |2 aat |0 (CStmoGRI)aat300054469 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Microbiology. |2 fast |0 (OCoLC)fst01019576 | |
| 650 | 7 | |a Medical microbiology. |2 fast |0 (OCoLC)fst01014362 | |
| 655 | 4 | |a Internet Resources. | |
| 776 | 0 | 8 | |i Electronic version: |a Tungland, Bryan. |t Human microbiota in health and disease. |d London, United Kingdom : Academic Press, an imprint of Elsevier, 2018 |z 9780128146507 |w (OCoLC)1038716467 |
| 776 | 0 | 8 | |i Print version: |a Tungland, Bryan. |t Human microbiota in health and disease. |d London, United Kingdom : Academic Press, an imprint of Elsevier, 2018 |z 9780128146491 |z 0128146494 |w (OCoLC)1015813921 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128146491 |z Texto completo |
| 856 | 4 | 1 | |u https://sciencedirect.uam.elogim.com/book/9780128146491 |z Texto completo |